Orilissa Tablet, Film Coated
Product Images NDC 0074-0038

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Orilissa (NDC 0074-0038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Orilissa Elagolix Tablets For Oral Use 01

Orilissa Elagolix Tablets For Oral Use 01
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 02

Orilissa Elagolix Tablets For Oral Use 02
This appears to be a table showing the number of subjects and dosage information for a medication called "ORILISSA". The dosages listed are 150mg once daily and 200mg twice daily. The table also includes the number of subjects for each dosage, as well as the number of subjects on and off treatment at different time points (month 0, month 6, and month 12). Without additional context or information, it is unclear what condition this medication is intended to treat.*
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 03

Orilissa Elagolix Tablets For Oral Use 03
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 04

Orilissa Elagolix Tablets For Oral Use 04
This is a not-available text.*
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 05

Orilissa Elagolix Tablets For Oral Use 05
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 06

Orilissa Elagolix Tablets For Oral Use 06
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 07

Orilissa Elagolix Tablets For Oral Use 07
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 08

Orilissa Elagolix Tablets For Oral Use 08
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 09

Orilissa Elagolix Tablets For Oral Use 09
Orilissa is a medication available in tablet form and is represented by the trademark symbol. The remaining text is not available for evaluation as it consists of symbols and non-English characters.*
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 0a

Orilissa Elagolix Tablets For Oral Use 0a
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 0b

Orilissa Elagolix Tablets For Oral Use 0b
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 0c

Orilissa Elagolix Tablets For Oral Use 0c
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 0d

Orilissa Elagolix Tablets For Oral Use 0d
FDA Label Image

Orilissa Elagolix Tablets For Oral Use 0e

Orilissa Elagolix Tablets For Oral Use 0e

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.